Alloy Therapeutics
Biologics & Biosimilars · Drug Discovery
$156.7Mtotal raised · 3 rounds on record
5open roles
$40Mlatest round · Series E · Apr 2026 · 6 mo ago
3backers · 8VC, JIC Venture Growth Investments
Overview
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in antibodies and TCRs.
Funding and backers
Total raised
$156.7M
3 rounds on record
Latest round
$40M
Series E · Apr 2026 · 6 mo ago
Team
51-200
employees, estimated range
Hiring now
7
+4 posted in 30 days
Backers
3
8VC, JIC Venture Growth Investments
The money's age
Fresh money
6 months since the last round · and hiring
Momentum
58/100
hiring for its size, in the news, fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 10
Recognition Alloy Therapeutics Named a Winner on Fast Company's 2026 Best Workplaces for Innovators List Morningstar · morningstar.com
Apr 19
Raised a round Series E $40M · Pulse 2.0
Sep 16, 2022
Raised a round Venture round $41.7M · SEC Form D
Apr 2, 2021
Board appointment Fabian Hansen, Director · SEC Form D
Mar 19, 2021
Raised a round Venture round $75M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series E | Apr 2026 | $40M | — | Pulse 2.0 |
| Venture round | Sep 2022 | $41.7M | — | SEC Form D |
| Venture round | Mar 2021 | $75M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Alloy Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Errik AndersonExecutive Officer, DirectorSEC Form D
Piotr BobrowiczExecutive Officer, DirectorSEC Form D
Logan SnyderDirectorSEC Form D
Jay RosanelliExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
JIC Venture Growth Investments 
Mubadala Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Solutions for drug discovery and diagnostics. SPR analysis, antibody selection and LFA services. K-One sensor chips & bioconjugates supply.
Antiverse combines generative AI and advanced antibody discovery to design functional, developable biologics for challenging drug targets.
Light Horse is a small molecule drug discovery company that is leading the way in a.
ABL Bio is a South Korean biotechnology company focused on developing innovative biologic drugs, with antibody, ADC and polynucleotide…
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting…
Jobs
In office · Waltham
Cell Culture
HPLC
Antibody Engineering
Apply
$46k – $64k per year · In office · Bachelor's Degree · Waltham
Flow Cytometry
Apply
≈ $115k – $203k per year (Estimated) · In office · 6+ years exp · PhD · Waltham
Flow Cytometry
Mass Spectrometry
Chromatography
Apply
≈ $46k – $118k per year (Estimated) · In office · PhD · Cambridge
CRISPR
PCR
Flow Cytometry
Western Blot
Next-Generation Sequencing
Antibody Engineering
Benchling
FlowJo
Apply
≈ $69k – $147k per year (Estimated) · In office · 5+ years exp · Bachelor's Degree · Waltham
PCR
Flow Cytometry
Cell Culture
Next-Generation Sequencing
Antibody Engineering
Apply
Visa sponsorship
5 ▲ 150%
H-1B filings in 12 months
$113k
Median offered salary
6
Open roles in United States
Who they sponsor
Other biological scientists
4
Medical scientists
1
In the register as Alloy Therapeutics, Inc., Waltham, MA
Other sponsors in the same field
Genentech 
Generate:Biomedicines 
Hexagon Bio
See 6 open roles Alert me
US Department of Labor · latest filing Jun 4, 2026 · Visa details by country
A-rated
Sponsor licence
Senior or Specialist Worker +1
Visa route
1
Open roles in United Kingdom
In the register as Alloy Therapeutics UK Limited, Cambridge
Other sponsors in the same field
Evotec 
Teva 
Sandoz 
BeOne Medicines
See 1 open role Alert me
UK Home Office · checked Nov 11, 2026 · Visa details by country
Growth
Hiring Momentum
28/100
Slowing
Open positions
7
0 opened / 0 closed in 30 days
Median time-to-fill
25 days
faster than 52% of the market
ATS activity
Every ~7 hours
11/11/2026
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
31% ▼
Operations
15% ▲
Security
8% ▼
Product
8% ▼
Administrative
8% ▲
HR
8% ▼
Activity Timeline
+8 jobs in a week
Sep 2026
People
Errik Anderson
Executive Officer, Director
Piotr Bobrowicz
Executive Officer, Director
Logan Snyder
Director
Jay Rosanelli
Executive Officer
Anthony Sun
Director
Alaa Halawa
Director
Ulrik Nielsen
Director
Jason Camm
Director
Jason Coloma
Director
Christian Kanady
Director
Alex Kolicich
Director
Fabian Hansen
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Alloy Therapeutics Named a Winner on Fast Company's 2026 Best Workplaces for Innovators List Morningstar
Read more
Report
Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure
Alloy Therapeutics announced it has raised $40 million in a Series E round, reaching a $1 billion valuation as it expands its AI-powered platform for drug discovery and development. The round included new investors such as 8VC, JIC Venture Growth Investme
Read more
Report
Alloy Therapeutics Appoints Alexander Titus, Ph.D., to Lead New Vigilance Division Focused on Biosecurity and Rapid Therapeutic Response
Read more
Report
Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform
BOSTON, March 17, 2026--Alloy Therapeutics, Inc. ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced an agreement with AbbVie to develop a new antibody platform to dis
Read more
Report
Report
Report
Multiomic Health and Alloy Therapeutics to partner on renal tissue-targeting drugs
Multiomic Health Ltd. and Alloy Therapeutics Inc. have signed a memorandum of understanding to jointly discover and develop first-in-class renal tissue-targeting drugs. Precision medicines for chronic renal conditions targeted to the kidney tissue of spec
Read more
Report
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
2
Busiest office
Waltham
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
Waltham
United States
HQ
Democratizing access to foundational biologics discovery technologies & services.
6 open roles 11 posted in 90 days 50-200 est. staff $64k Avg Salary
hires for Biotech, Administrative, Operations
275 Second Ave, Suite 200, Waltham, MA 02451
Cambridge
United Kingdom
1 open roles 1 posted in 90 days 10-50 est. staff
hires for Biotech